Shortcut to Body Shortcut to main menu

Local Governments

  • Home
  • Investment Opportunities
  • Sites
  • Local Governments
[Dae-gu] Daegu-Gyeongbuk High-tech Medical Complex
Date
2014.09.18

Daegu-Gyeongbuk High-tech Medical Complex (Medivalley)

Medivalley is an advanced medical technology cluster, that is nationally designated to strategically foster a world-class pharmaceutical and medical device industries to lead the global medical market

Overview

  • Location: Sinseo-dong, Dong-gu, Daegu City
  • Project Period: 2009 ~ 2038 (Construction or ndustrial complex 2009~2013)
  • Gross Area: 1,026,000 ㎡ (Business and R&D zones 439,000 ㎡)
  • Implementer: Korea Land and Housing Corporation (LH)
  • Project Cost: KRW4.6 trillion

Site Conditions

  • Target Sector: Manufacturing and R&D about pharmaceuticals and advanced medical devices
  • Rent: KRW 2.85 million/3.3㎡
  • Occupancy Rate
    (As of January, 2023)
    산업단지 분양실적을 나타내는 표
    Land Use Planning Total Area (1,000 ㎡) Number of Tenants Occupied (1,000 ㎡) For rent (1,000 ㎡) Occupancy Rate (%)
    Business and R&D Zone 439 27 entities* 341 98 77.8
    ※ Additional tenants: 32 entities in Korea Mediventure Center located within Daegu-Gyeongbuk High-tech Medical Complex (lot for sale), 6 entities in Communication Center (lease), 5 entities in New Drug Development Center (lease), 7 entities in 3D Convergence Technology Center (lease)
  • Access: Medivalley is connected with 8 express ways through Dongdaegu (East Daegu) IC, an entrance ramp to Gyeongbu Expressway
    It is 5 minutes’ walk from a station of Daegu Metro line 1
  • Key Feature: The best place to live and work as it is located within Daegu innovation city
    The best national medical R&D cluster
    (Four core infrastructures that include those for drug development and cutting-edge medical devices, Korea Brain Research Institute)
    Regulatory special cases according to Special Act on the Designation and Support of High-tech Medical Complexes and Regulation-Free Special Zone on Smart Wellness

Major Tenant

  • Corporation: DongSung Pharm., Lutroinc, Jamlim Pharm., Surgident, Korea Pharma
  • Research Center: Daegu Gyeongbuk Medical Innovation Foundation (DGMIF), Advanced Clinical Trial Center, Korea Brain Research Institute, Laboratory Animal Resources Bank, Training Center for Medical Technology and Test, etc.
  • Support Agency: Daegu Regional FDA

Target Institution

  • Institutions designed for medical R&D (pharmaceuticals or medical devices)
  • Institutions that create and run departments in charge of medical R&D
    - Medical institutions
    - R&D centers (including annex research institutes of those in charge of pharmaceuticals, medical devices, or the health and medical technology industry)

Layout Map

하단에 내용 참고바랍니다. 하단에 내용 참고바랍니다.이미지 크게보기
Meta information